Voyager Therapeutics
VYGR
56 hedge funds and large institutions have $140M invested in Voyager Therapeutics in 2016 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 22 increasing their positions, 13 reducing their positions, and 7 closing their positions.
69% more repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 13
60% more capital inflows, than outflows
Capital inflows: $11.5M | Capital outflows: $7.15M
57% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 7
6% more funds holding
Funds holding: 53 → 56 (+3)
1.18% more ownership
Funds ownership: 39.81% → 41% (+1.2%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Adage Capital Partners
Boston,
Massachusetts
|
+$3.16M |
| 2 |
Casdin Capital
New York
|
+$1.39M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$1.32M |
| 4 |
Altrinsic Global Advisors
Stamford,
Connecticut
|
+$1.28M |
| 5 |
BlackRock Fund Advisors
San Francisco,
California
|
+$712K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
-$3.69M |
| 2 |
PIM
Partner Investment Management
San Francisco,
California
|
-$1.64M |
| 3 |
Ascend Capital
Orinda,
California
|
-$700K |
| 4 |
Globeflex Capital
San Diego,
California
|
-$426K |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$153K |
VYGR Hedge Fund Activity: Q4 2016 in Review
56 of the 4,008 institutional investors tracked by Wall St. Rank reported a position in Voyager Therapeutics (VYGR) for Q4 2016, worth a combined $140M — up 9.2% from $128M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new VYGR positions and 7 closed out — a net gain of 4 holders — while 22 added to existing stakes and 13 trimmed.
The largest buyer was Adage Capital Partners, adding an estimated $3.16M. The largest seller was Goldman Sachs, cutting an estimated $3.69M.
- 56 institutional investors held Voyager Therapeutics (VYGR) as of Q4 2016, up from 53 in Q3 2016.
- Funds reported $140M of Voyager Therapeutics stock for Q4 2016, up 9.2% quarter-over-quarter.
- 11 funds opened new Voyager Therapeutics positions in Q4 2016 and 7 closed out, a net change of +4 holders.
- The largest Voyager Therapeutics buyer in Q4 2016 was Adage Capital Partners, an estimated $3.16M added.
- The largest Voyager Therapeutics seller in Q4 2016 was Goldman Sachs, an estimated $3.69M sold.
Based on aggregated 13F filings for Q4 2016.